Help us raise awareness of neuroblastoma throughout September. Read more
In a landmark in paediatric oncology research, children with high-risk neuroblastoma across Europe and North America will be treated together for the first time. Read more
Register your interest in becoming an Ambassador for Solving Kids' Cancer and be part of our vision for a future where no child dies of the childhood cancer neuroblastoma or suffers due to its treatment. Read more
Grant Award - High-Risk Neuroblastoma Clinical Trial 2 Read more
Read more
2019 Solving Kids’ Cancer Neuroblastoma Parent Education Conference. Read more
Our 2018 conference offered a concurrent session focusing on ways to deal with and manage the long-term side effects of neuroblastoma. Read more
Our 6th Annual Neuroblastoma Parent Education Conference – ‘Understanding the Landscape of Neuroblastoma Research’ Read more
Solving Kids’ Cancer brings a particular ethos to the way that we approach our research-related activities. Read more
Help the fight against neuroblastoma by leaving a gift in your Will. The legacy you leave could fund research that finds the cure for this horrible childhood cancer. Read more
In April each year Solving Kids’ Cancer will issue a Request for Applications (RFA) inviting researchers to submit their ideas to us as part of a Competitive Funding Call process. Read more
Our 5th Annual Neuroblastoma Parent Education Conference was held at Latimer Place in Chesham Read more
Our 4th Annual Parent Conference was again held at Latimer Place, Chesham Read more
We provide evidence-based and impartial information to help families choose treatment options for their child and to access treatments and clinical trials if they are not available on the NHS. Read more
The BEACON study is a chemotherapy and antibody combination trial. Read more
The National Neuroblastoma Genetics Reference Centre aims to provide a comprehensive service genetic characterisation of all neuroblastoma tumours at diagnosis and a subset at relapse. Read more
Find out how our Neuroblastoma Parent Education Conference has ‘Patients Included’ status, demonstrating our commitment to ensuring it delivers research and clinical information that is important to parents and guardians of children with neuroblastoma. Read more
It’s important to Solving Kids’ Cancer that we work closely and collaborate with other charities that offer support, distribute useful information and fund research in neuroblastoma. Read more
Bringing together American NCI PPTC and European ITCC-P4 paediatric preclinical research consortiums together for the first time ever via the Pediatric Cancer Working Group at the AACR Annual Meeting. Read more
MiNivAn aims to improve the cure rate of children with relapsed or refractory neuroblastoma by combining targeted radiotherapy (I-131 MIBG) with the antibodies anti-GD2 (ch14.18/CHO) and anti-PD1 (nivolumab). Read more
In this study, blood and bone marrow samples from 120 children treated in the BEACON-Neuroblastoma trial will be collected in order to analyse levels of neuroblastoma mRNAs Read more
This exciting new clinical trial sees 17 transatlantic centres in the UK, USA and Europe, recruiting patients simultaneously for an innovative new third-generation ALK-inhibitor agent lorlatinib (PF-06463922). Read more
The aim of immunotherapy is to keep your child in remission and keep the cancer away Read more
Give something extra special this Christmas by purchasing a gift that benefits Solving Kids' Cancer. Read more